Cuervas-Mons V, Rimola A, Van Thiel D H, Gavaler J S, Schade R R, Starzl T E
Gastroenterology. 1986 Apr;90(4):853-7. doi: 10.1016/0016-5085(86)90860-7.
The medical, anesthesia, and surgical records of 89 consecutive pediatric patients who underwent an orthotopic hepatic transplantation procedure at the University of Pittsburgh from February 1981 to May 1984 were reviewed to evaluate the effect of prior abdominal surgery upon the morbidity and mortality of orthotopic liver transplantation in children. Fifty-seven children (group 1) had had prior abdominal surgery, whereas 32 (group 2) had not. The group 1 subjects were younger (p less than 0.001), had better prothrombin times (p less than 0.01), and better platelet counts (p less than 0.02) than did those in group 2. No difference in the duration of anesthesia or intraoperative use of fresh frozen plasma or platelets was evident between the two groups. However, group 1 patients were given more red blood cells intraoperatively than were the group 2 patients (p less than 0.01). The group 1 patients had more total postoperative infections (p less than 0.05), which was due solely to a greater number of abdominal infections (p less than 0.05), but similar total hospital and intensive care unit stays as did the group 2 patients. When those in group 1 were divided into those having a previous Kasai procedure versus those who did not, no differences between the two groups were apparent except for age. Based upon these data, we conclude that prior abdominal surgery does not affect mortality, the duration of hospital or intensive care unit stay, plasma or platelet requirements, and total anesthesia time required for orthotopic liver transplantation, but does enhance the number of red blood cell transfusions and infections, particularly abdominal infections, in children undergoing this procedure.
回顾了1981年2月至1984年5月在匹兹堡大学接受原位肝移植手术的89例连续儿科患者的医学、麻醉和手术记录,以评估既往腹部手术对儿童原位肝移植发病率和死亡率的影响。57名儿童(第1组)曾接受过腹部手术,而32名(第2组)没有。第1组患者比第2组患者年龄更小(p<0.001),凝血酶原时间更好(p<0.01),血小板计数更高(p<0.02)。两组之间麻醉持续时间、术中新鲜冰冻血浆或血小板的使用情况没有明显差异。然而,第1组患者术中输注的红细胞比第2组患者更多(p<0.01)。第1组患者术后总感染更多(p<0.05),这完全是由于腹部感染数量更多(p<0.05),但与第2组患者的总住院时间和重症监护病房住院时间相似。当第1组患者分为曾接受过Kasai手术的患者和未接受过Kasai手术的患者时,除年龄外,两组之间没有明显差异。基于这些数据,我们得出结论,既往腹部手术不影响原位肝移植的死亡率、住院或重症监护病房住院时间、血浆或血小板需求以及所需的总麻醉时间,但会增加接受该手术儿童的红细胞输注量和感染数量,尤其是腹部感染。